Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2025 | Incidence and clinical outcomes of erythrocytosis associated with SGLT2 inhibitors

Ji Yun Lee • 13 Jun 2025
EHA 2025
General

In this presentation, Ji Yun Lee, MD, PhD, Seoul National University Bundang Hospital, Seongnam, South Korea, shares insights into a study exploring the incidence and clinical outcomes of erythrocytosis associated with SGLT2 inhibitors. This press briefing took place at the 30th Congress of the European Hematology Association (EHA) in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Related Videos

Using artificial intelligence to accelerate patient eligibility screening in clinical trials 1:52
Using artificial intelligence to accelerate patient eligibility screening in clinical trials
Aaron Gerds • 5 Dec 2025
Expanding CAR-T therapy to smaller centers to meet rising demand 1:28
Expanding CAR-T therapy to smaller centers to meet rising demand
Sunil Gupta • 5 Dec 2025
Replacing standard FISH panels with WGS in multiple myeloma 1:49
Replacing standard FISH panels with WGS in multiple myeloma
Francesco Maura • 8 Dec 2025
Results of a survey investigating fertility and outcomes after CAR T-cell therapy 1:13
Results of a survey investigating fertility and outcomes after CAR T-cell therapy
Florent Malard • 7 Dec 2025
The content of VJHemOnc is intended for healthcare professionals